58 articles in this topic
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.
UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
Brain scans reveal how testosterone suppression in prostate cancer treatment could lead to cognitive decline in aging men.
